{"summary": "DNA vaccines have emerged as attractive candidates for the control of human papillomavirus (HPV)-associated malignancies. however, DNA vaccines suffer from limited immunogenicity and thus strategies to enhance DNA vaccine potency are needed. we have previously demonstrated that for DNA vaccines encoding calreticulin linked enhances both the E7-specific CD8+ T cell immune responses and antitumor effects against E7-expressing tumors. for the control of infection and/or cancer."}